Cancer Drug Prices
-
{
- All
- News
- Videos
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed By Over 90%, But Experts Say One-Time Cuts Won't End Overpricing
Public health group, Jan Swastha Abhiyaan has demanded cost-based price controls, permanent caps on trade margins and independent verification of cancer drug prices.
-
Cancer Drugs Price Cut: Generics Get Cheaper, But The Most Expensive Medicines Escape The Cut
The National Pharmaceutical Pricing Authority (NPPA) has revised the maximum retail prices (MRPs) of 543 cancer drug brands and pack sizes after the government capped trade margins on 137 non-scheduled anti-cancer medicines at 30 per cent.
-
Cancer Drug Price Cut: Govt Caps Trade Margins At 30%, Revises Prices Of 543 Drug Brands
Cancer patients could see lower medicine bills as the NPPA revises maximum retail prices for 543 anti-cancer drug brands. The new rates take effect on November 9, 2026, with some listed medicines recording substantial price reductions.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
137 Cancer Drugs To See Up To 70% Price Cut From November 9
The revised, lower prices are scheduled to officially take effect on November 9, 2026. Patients can check revised prices on the NPPA website and Pharma Sahi Daam app.
-
After Cancer Drug Price Cap, Karnataka Seeks Similar Relief For Heart, Kidney Patients
Karnataka has asked the Centre to extend price safeguards to expensive medicines used for cardiac and kidney diseases after the government approved a 30% trade-margin cap for non-scheduled anti-cancer drugs.
-
Supreme Court Questions Centre Over Massive Markup Gaps In Cancer Drug Prices
The Supreme Court questioned the Centre over huge differences between the MRP and PTR of cancer drugs, asking why essential life-saving items lack price control.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
The Story Of Extortive Prices For Cancer Drugs And Whether The Government Has Done Enough
Did you know that trade mark ups for some cancer drugs were as high as 1,500%.
-
The Story Of Extortive Prices For Cancer Drugs And Whether The Government Has Done Enough
Did you know that trade mark ups for some cancer drugs were as high as 1,500%.
-
Government Slashes Price Of 390 Non-Scheduled Cancer Drugs By Upto 87%
Manufacturers, hospitals were directed to convey the revised MRP, to be effective from March 8, based on the trade margin formula.
-
Cancer Drug Prices Slashed Up To 86% In A Year: Regulator
The other pharma players the prices whose cancer medicines have been reduced are Natco Pharma and Emcure pharmaceuticals among others, it added.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
Cancer Drugs Least Affordable In India, China; Prices Highest In US
The study of cancer drug prices in seven countries, which did not take into account discounts or rebates to list prices, was presented at the annual meeting of the American Society of Clinical Oncology in Chicago.
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed By Over 90%, But Experts Say One-Time Cuts Won't End Overpricing
Public health group, Jan Swastha Abhiyaan has demanded cost-based price controls, permanent caps on trade margins and independent verification of cancer drug prices.
-
Cancer Drugs Price Cut: Generics Get Cheaper, But The Most Expensive Medicines Escape The Cut
The National Pharmaceutical Pricing Authority (NPPA) has revised the maximum retail prices (MRPs) of 543 cancer drug brands and pack sizes after the government capped trade margins on 137 non-scheduled anti-cancer medicines at 30 per cent.
-
Cancer Drug Price Cut: Govt Caps Trade Margins At 30%, Revises Prices Of 543 Drug Brands
Cancer patients could see lower medicine bills as the NPPA revises maximum retail prices for 543 anti-cancer drug brands. The new rates take effect on November 9, 2026, with some listed medicines recording substantial price reductions.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
137 Cancer Drugs To See Up To 70% Price Cut From November 9
The revised, lower prices are scheduled to officially take effect on November 9, 2026. Patients can check revised prices on the NPPA website and Pharma Sahi Daam app.
-
After Cancer Drug Price Cap, Karnataka Seeks Similar Relief For Heart, Kidney Patients
Karnataka has asked the Centre to extend price safeguards to expensive medicines used for cardiac and kidney diseases after the government approved a 30% trade-margin cap for non-scheduled anti-cancer drugs.
-
Supreme Court Questions Centre Over Massive Markup Gaps In Cancer Drug Prices
The Supreme Court questioned the Centre over huge differences between the MRP and PTR of cancer drugs, asking why essential life-saving items lack price control.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
The Story Of Extortive Prices For Cancer Drugs And Whether The Government Has Done Enough
Did you know that trade mark ups for some cancer drugs were as high as 1,500%.
-
The Story Of Extortive Prices For Cancer Drugs And Whether The Government Has Done Enough
Did you know that trade mark ups for some cancer drugs were as high as 1,500%.
-
Government Slashes Price Of 390 Non-Scheduled Cancer Drugs By Upto 87%
Manufacturers, hospitals were directed to convey the revised MRP, to be effective from March 8, based on the trade margin formula.
-
Cancer Drug Prices Slashed Up To 86% In A Year: Regulator
The other pharma players the prices whose cancer medicines have been reduced are Natco Pharma and Emcure pharmaceuticals among others, it added.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
Cancer Drugs Least Affordable In India, China; Prices Highest In US
The study of cancer drug prices in seven countries, which did not take into account discounts or rebates to list prices, was presented at the annual meeting of the American Society of Clinical Oncology in Chicago.
